Biotech Values

[ghmm]

They are on retailroadshow now and show is Unum Therapeutics

https://www.retailroadshow.com/

Thanks for pointing out the valuation comp to Gene Editing companies (I don't really follow that area). Not sure how I see them since they are both. Seeing that they have over 100m in cash already the EV (at say $15 IPO) would be about 300m so not quite as bad but still, they are preclinical and I don't like their lead programs in both Gene Editing and Gene Therapy are in PKU (too competitive).